MEK Iran: Regime’s Maffia of Medicine Responsible for Thousands of Death
Mismanagement and inhuman policies of the mullahs’ regime make the coronavirus spread again in Iran, with the people paying the daily price with their lives. The mullahs tried to use the death toll as a tool to break the US sanctions and the maximum pressure campaign.
First, the regime claimed that the US had sanctioned medicine to blackmail the world community while none of the regime policies is to help the people or in their interests.
The People’s Mojahedin Organization of Iran (PMOI / MEK Iran) has announced on Saturday, May 30, 2020, that the Coronavirus death toll in 323 cities across Iran is at least 48.000 people.
— People's Mojahedin Organization of Iran (PMOI/MEK) (@Mojahedineng) May 30, 2020
The Iranian regime uses medicine mafias as an instrument to loot the Iranian people’s national assets: a deadly business with the aim of self-victimization.
With the outbreak of the deadly coronavirus, the Iranian regime Foreign Minister Javad Zarif repeatedly said that the US sanctions ban the sale of medicine, and this is the reason the lives of many are in danger.
The Iranian regime officials use coronavirus affected people and victims in need of medicine as an excuse to cover up their crimes.
In addition to many official production companies, medicine importers also play a significant role in mafia corruption. These companies import low-quality chemicals and other items needed for the preparation of medicines from China and produce them with formulas provided by Chinese companies in Iran and then offer them in the market at exorbitant prices.
Interestingly, all these companies use government currency to import low-quality Chinese raw material, and after production, they market the drug at a free price. Last year, after a sudden and unprecedented rise in currency rates in Iran, government officials allocated a currency rate of 4,200 Toumans for a dollar for imports. While at the moment, a dollar is equivalent to 20.000 Touman.
According to the Korea Humanitarian Trade Agreement, an Iranian bank that has not been sanctioned by the United States is used to activate humanitarian trade with Iran to send some essential items such as medicine, medical equipment, and quarantine needs to Iran. South Korea is using the Swiss Agreement and the General Permit No. 8 of the US Government – a mechanism that allows humanitarian trade with Iran to be carried out through the Central Bank – to resume philanthropic business with Iran.
As another example, the Trade Development Organization of Iran has officially announced that in 2018, Iran exported 95 million dollars of chemical medicines weighing 2,400 tons to other countries. The essential drug importers from Iran are Germany, Russia, Syria, Afghanistan, Iraq, and India.
Iranian travelers traveling to Iraq, Azerbaijan, and Afghanistan have reportedly encountered a wealth of Iranian-made drugs in these countries.
The Daily Sharq mentioned on July 20, 2019, a letter from the Iranian president Hassan Rouhani’s Head of Office, who reported that one billion dollars of government currency paid for the import of medicine and essential goods have been “lost.”
In this letter, it is mentioned that ten companies for the import of medicine and ten other companies for the import of essential goods have not imported several products in exchange for the received government currency.
These governmental agencies also prevent the import of medicine by reputable international companies as well as charities.
(Pharma Exports to Iran: EU and Swiss)
However, according to the above statistics, pharmaceutical exports from Europe and Switzerland to Iran have not changed, which means that the regime has continued to receive its medicine imports as in previous years.
The Health Minister Saeed Namaki said on September 16, 2019, that some importers had received two million euros in government currency for importing heart stents, but instead, have imported power cables and then escaped the country.
A day before, Hosein, Naghavi Hoseini, member of the Majlis (Parliament), quoted the Minister of Health in a meeting with the MPs that “corruption worth of 50,000 billion tomans in medicine” has taken place.
The medicines which the Islamic Republic claimed were lacking in the Iranian market are all related to specific and incurable diseases.
The medicine shortage raised the number of death among patients, and following that, the regime victimizes itself in the eyes of the international community. Patients and their families are forced to meet their needs from the free and informal market at exorbitant prices, which government profit of it.
As an example, pharmaceutical distribution companies tell pharmacies that if you want to get metformin from Hexal, you must first buy a large amount of metformin produced by a specific Iranian factory. Then you can get a few limited boxes of metformin of the Hexal brand!
Some other medicines not produced in the country sell in the same way. For example, Warfarin, which does not have an Iranian equivalent, is given to the pharmacy when the pharmacy has bought at least a few million Toumans worth other products of the importing company.
Some brands, such as Hexal Germany or Novonordisk, are allowed to operate in the Iranian market when they share their product-line with foundations such as Barakat in Iran.
The central control of medicine mafia in Iran is managed by people like Dr. Abbas Kebriyayizadeh (president of the union) and Dr. Gholamreza Asghari (deputy minister of health and medical education and head of the Food and Medicine Administration), and Dr. Dinarvand, former head of the Food and Medicine Administration and Dr. Mahmoudi.
At the time of his studies, Dr. Abbas Kebriayizadeh worked in the Basij (a branch of the Revolutionary Guards). He visited the battlefield, and his left hand was injured then.
These people have imported the most significant amount of low-quality Chinese raw material in recent years.
The regime’s false claims about medicine sanctions can be traced to the following diagrams:
(EU pharma Exports to Iran)
The chart of Europe medicine exports to Iran
Compared to previous years, there has been no change in the delivery of medicine to Iran.
(EU pharma Imports From Iran)
The chart of Iran medicine exports to Europe
In 2019, Iran had the highest medicine exports compared to previous years, which is very significant. The active medicine mafia of the Iranian regime has left fewer medicines available to the Iranian people at a higher price.
Therefore, the embargo on medicine imports and exports is false. The Iranian regime is playing with the life of the Iranian people and is covering up its crimes. The regime’s supreme leader Ali Khamenei tries to use the coronavirus as a tool and an opportunity to maintain his regime in power, while the Iranian people are poised to prevent the regime from turning the coronavirus outbreak into another excuse to continue its rule.